STOCKHOLM, Dec 20 (Reuters) - U.S. Pfizer is unlikely to come back with a fresh bid for AstraZeneca , the Anglo-Swedish pharmaceuticals group's top executive was quoted as saying by Swedish business...
Dec 19 (Reuters) - AstraZeneca Plc 's ovarian cancer drug has been granted an accelerated approval by the U.S. health regulator, a day after the treatment was approved by the European Commission.
Dec 19 (Reuters) - AstraZeneca Plc 's ovarian cancer drug has been granted an accelerated approval by the U.S. health regulator, a day after it was approved by the European Commission.
LONDON, Dec 18 (Reuters) - AstraZeneca 's all-important cancer drug business received a fillip on Thursday as a new medicine against ovarian cancer was approved in Europe, making it the first of its...
* Lynparza approved in European Union as first-in-class treatment for advanced BRCA-mutated ovarian cancer Source text for Eikon: Further company coverage:
Profile in United States Anesthetic Drugs Market Baxter International Inc Endo Health Solutions Inc Abbott Laboratories AstraZeneca Data Sources This report is built using data and information sourced from proprietary databases, primary and secondary
LONDON, Dec 9 (Reuters) - AstraZeneca 's new drug for the treatment of opioid-induced constipation, which was developed with Nektar Therapeutics, has been approved in the European Union, the British company said on Tuesday.
* Moventig approved in european union for opioid-induced constipation Source text for Eikon: Further company coverage:
Dec 5 (Reuters) - A Massachusetts jury has found that an agreement between AstraZeneca Plc and Ranbaxy Laboratories Ltd to delay the launch of a generic version of AstraZeneca 's heartburn drug Nexium...
LONDON, Dec 5 (Reuters) - AstraZeneca said a jury in the U.S. ruled in its favour in an antitrust litigation over heartburn drug Nexium, a case brought against it by various buying groups who challenged a previous settlement.